Showing results (111-120 of 140) with videos related to
Sort By:
Pageof 14
Journal of Cancer|June 21, 2021
RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancerSung-Hwa Sohn, Hee Jung Sul, Bohyun Kim, et al.Diabetes Research and Clinical Practice|July 16, 2013
Design and preliminary results of a metropolitan lifestyle intervention program for people with metabolic syndrome in South KoreaYo-Han Lee, Seok-Jun Yoon, Hyeong-Su Kim, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2019
Characterization of Hagfish (Eptatretus burgeri) Variable Lymphocyte Receptor-Based Antibody and Its Potential Role in the Neutralization of Nervous Necrosis VirusJae Wook Jung, Jung Seok Lee, Jaesung Kim, et al.BMC Cancer|October 28, 2010
Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancerDo Hyoung Lim, Se Hoon Park, Keon Woo Park, et al.Cancer Chemotherapy and Pharmacology|January 22, 2010
Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancerJung Hye Kwon, Jung Han Kim, Jung-Ae Lee, et al.Oncology Letters|August 1, 2012
A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancerJung Han Kim, Hyeong Su Kim, Dae Ro Choi, et al.Oncology Letters|June 29, 2012
Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance statusHyeong Su Kim, Jung Han Kim, Hee Jun Kim, et al.Lung Cancer (Amsterdam, Netherlands)|January 26, 2010
A phase II study of pemetrexed and carboplatin as a salvage therapy for platinum-pretreated patients with non-small cell lung cancerHyeong Su Kim, Gyeong-Won Lee, Jung Han Kim, et al.Lung Cancer (Amsterdam, Netherlands)|July 16, 2008
Systemic chemotherapy after cranial irradiation in patients with brain metastases from non-small cell lung cancer: a retrospective studyJung Han Kim, Hyeong Su Kim, Jung Hye Kwon, et al.Lung Cancer (Amsterdam, Netherlands)|November 22, 2008
Bilateral subdural hemorrhage as a possible adverse event of gefitinib in a patient with non-small cell lung cancerJung Han Kim, Hyeong Su Kim, Jong Soo Choi, et al.Pageof 14